Wellington Management Group LLP Buys 103,044 Shares of The Cooper Companies, Inc. $COO

Wellington Management Group LLP grew its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 3.1% during the second quarter, HoldingsChannel reports. The fund owned 3,468,951 shares of the medical device company’s stock after acquiring an additional 103,044 shares during the quarter. Wellington Management Group LLP’s holdings in Cooper Companies were worth $248,758,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in COO. Avalon Trust Co purchased a new position in Cooper Companies in the second quarter valued at about $25,000. Root Financial Partners LLC lifted its position in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares during the last quarter. SJS Investment Consulting Inc. lifted its position in shares of Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after buying an additional 187 shares during the last quarter. Elevation Wealth Partners LLC boosted its holdings in shares of Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after buying an additional 375 shares in the last quarter. Finally, J.Safra Asset Management Corp bought a new position in shares of Cooper Companies during the 2nd quarter worth approximately $32,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Performance

NASDAQ COO opened at $71.17 on Monday. The company has a fifty day simple moving average of $72.56 and a two-hundred day simple moving average of $70.81. The stock has a market cap of $13.88 billion, a P/E ratio of 60.31, a P/E/G ratio of 1.86 and a beta of 0.83. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the previous year, the firm posted $0.96 earnings per share. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. BNP Paribas Exane lowered their target price on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, June 8th. Piper Sandler set a $86.00 price target on Cooper Companies and gave the stock an “overweight” rating in a research report on Monday, June 1st. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a report on Wednesday, May 27th. UBS Group initiated coverage on Cooper Companies in a research report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 price objective for the company. Finally, Robert W. Baird dropped their target price on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.